Globally, venture capital firms invested over $52 billion into biotech startups, counting investments from seed to series C. The largest proportion of funding went to platform-based therapeutics, bringing in $34.6 billion in total, while other therapeutics accounted for $17.2 billion in funding.
Here are five platform-based startup types to watch, as they received the most VC investment:
- Cell therapy represented $7.7 billion of total funding.
- Next-generation gene therapies brought in $7.6 billion in funding.
- Precision medicine companies got $4.5 billion in funding.
- Machine-learning-enabled drug discovery brought in $4.4 billion.
- Startups focusing on hard-to-hit targets, or “undruggable” targets, got $4 billion in funding.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
